Lindbrook Capital’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.68K | Buy |
165
+76
| +85% | +$774 | ﹤0.01% | 2332 |
|
|
2024
Q4 | $1.41K | Sell |
89
-24
| -21% | -$380 | ﹤0.01% | 2402 |
|
|
2024
Q3 | $6.56K | Buy |
113
+24
| +27% | +$1.39K | ﹤0.01% | 1891 |
|
|
2024
Q2 | $4.07K | Hold |
89
| – | – | ﹤0.01% | 2096 |
|
|
2024
Q1 | $5.89K | Hold |
89
| – | – | ﹤0.01% | 1829 |
|
|
2023
Q4 | $3.54K | Buy |
89
+70
| +368% | +$2.78K | ﹤0.01% | 2059 |
|
|
2023
Q3 | $606 | Buy |
+19
| New | +$606 | ﹤0.01% | 2499 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2810 |
|
|
2023
Q1 | – | Sell |
-38
| Closed | -$1.83K | – | 2861 |
|
|
2022
Q4 | $1.83K | Buy |
38
+21
| +124% | +$1.01K | ﹤0.01% | 2270 |
|
|
2022
Q3 | $1K | Buy |
17
+9
| +113% | +$529 | ﹤0.01% | 2379 |
|
|
2022
Q2 | $0 | Sell |
8
-9
| -53% | – | ﹤0.01% | 2645 |
|
|
2022
Q1 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 2273 |
|